Mucosal immune network in the gut for the control of infectious diseases

Reviews in Medical Virology

Volumn 11, Issue 2, 2001, Pages 117-133

  Iijima, Hideki ^a   Takahashi, Ichiro ^a   Kiyono, Hiroshi ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHOLERA TOXIN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; VACCINE;

ANTIBODY DETECTION; ANTIGEN SPECIFICITY; CYTOKINE PRODUCTION; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; INFECTION CONTROL; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE SUBPOPULATION; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; COMMUNICABLE DISEASES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, MUCOSAL; MICE; STOMACH;

EID: 0035061328     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.307     Document Type: Review

References (122)

1. The mucosal immune system
2. The mucosal immune system; from fundamental concepts to vaccine development
3. Molecular mechanisms of immunoglobulin A defense
4. Mucosal vaccines: Areas arising
5. Regulation of IgA synthesis and immune response by T cells and interleukins
6. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix and Peyer's patches: An electron microscopic study
7. Epithelial cell specialization within human Peyer's patches; and ultrastructural study of internal lymphoid follicles
8. The membranous epithelial (M) cell and the mucosal immune system
9. Epithelial M cells: Gateways for mucosal infection and immunization
10. M cells in Peyer's patches of the intestine
11. Uptake and transport of copolymer biodegradable micro-spheres by rabbit Peyer's patch M cells
12. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria
13. Organogenic role of B lymphocytes in mucosal immunity
14. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the Peyer's patches
15. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells
16. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3α, MIP-3β, and secondary lymphoid organ chemokine
17. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production
18. Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type β-induced isotype switching
19. The role of helper T cell products in mouse B cell differentiation and isotype regulation
20. The receptor for transepithelial transport of immunoglobulin: Synthesis of secretory component as contains multiple and large transmembrane forms
21. Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man
22. Transepithelial transport of immunoglobulins
23. Synergistic effect of IL-4 and IFN-γ on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells
24. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells
25. B220, a B cell specific member of the T200 glycoprotein family
26. Origin of murine B cell lineages
27. Many of the IgA producing plasma cells in the murine gut are derived from self-replenishing precursors in the peritoneal cavity
28. Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues
29. Involvement of B-1 cells in mucosal immunity and autoimmunity
30. Interleukin 15 and IL-15R selectively regulate differentiation of common mucosal immune system-independent B-1 cells for IgA responses
31. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria
32. The T cell receptor
33. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis
34. Spontaneous in vitro evolution of lytic specificity of cytotoxic T lymphocyte clones isolated from murine intestinal epithelium
35. Leukocytes in the intestinal epithelium: An unusual immunological compartment
36. The effect of antigen deprivation on thymus-dependent and thymus-independent lymphocytes in the small intestine of mouse
37. Morphometric analysis of intestinal mucosa. VI. Principals in enumerating intra-epithelial lymphocytes
38. + intraepithelial lymphocytes
39. Cytotoxic differentiation of mouse gut thymodependent and independent intraepithelial T lymphocytes is induced locally. Correlation between functional assays, presence of perforin and granzyme transcripts and cytoplasmic granules
40. + T cells in murine intestinal epithelium
41. Memory and distribution of virus-specific cytotoxic T lymphocytes(CTLs) and CTL precursors after rotavirus infection
42. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice
43. Protective effect of rotavirus VP-6-specific IgA monoclonal antibodies that lack neutralizing activity
44. Gamma/delta cells
45. Differential production of interferon-γδ and interleukin-4 in response to Th1- and Th2-stimulating pathogen by γδ T cells in vivo
46. Protective role of γδ T cells and αβ T cells in tuberculosis
47. γ/δ T cell-deficient mice have impaired mucosal immunoglobulin A responses
48. Recognition by γ/δ T cells
49. The nature of major histocompatibility complex recognition by γδ T-cells
50. Stimulation of human γδ T-cells by nonpeptidic mycobacterial ligands
51. Influence of β2-microglobulin expression on gamma interferon secretion and target cell lysis by intraepithelial lymphocytes during intestinal Listeria monocytogenes infection
52. The CD1 family: A third lineage of antigen-presenting molecules
53. Ligation of intestinal epithelial CD1d induces bioactive IL-10: Critical role of the cytoplasmic tail in autocrine signaling
54. T-cell recognition of non-peptide antigens
55. CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor
56. Recognition of a peptide antigen by heat shock-reactive γδ T lymphocytes
57. The extra-thymic T-cell development pathway
58. + T cells are found in intestinal intraepithelial lymphocytes of mice that lack classical MHC class I molecules
59. Generation of intestinal mucosal lymphocytes in SCID mice reconstituted with mature, thymus-derived T cells
60. + lympho-hemopoietic progenitors develop
61. An opposite pattern of selection of a single T cell antigen receptor in the thymus and among intraepithelial lymphocytes
62. Systemic activation and antigen-driven oligoclonal expansion of T cells in a mouse model of colitis
63. Studies on the chemistry of anaphylaxis (III). Experiments with isolated proteins, especially those of the hen's egg
64. Peripheral deletion of antigen-reactive T cells in oral tolerance
65. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin
66. Clonal expansion versus functional clonal inactivation: A costimulatory signaling pathway determines the outcome of T-cell antigen receptor occupancy
67. Oral tolerance
68. + T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production
69. Lack of orally induced systemic unresponsiveness in IFN-γ knockout mice
70. Oral tolerance in experimental autoimmune encephalomyelitis III. Evidence for clonal anergy
71. Peripheral deletion of antigen-reactive T cells in oral tolerance
72. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions
73. + cells mediate active suppression
74. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin-4, and prostaglandin E expression in the brain
75. Immunomodulation of experimental autoimmune diseases via oral tolerance
76. γδ and other unconventional T lymphocytes: What do they see and what do they do?
77. γδ T lymphocytes regulate the induction and maintenance of oral tolerance
78. Gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion
79. + T cells in ovalbumin TCR transgenic mice
80. + T cells as a functionally and phenotypically distinct immuno-regulatory T cell subpopulation
81. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
82. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance
83. Control of immune pathology by regulatory T cells
84. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
85. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
86. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
87. + regulatory cells that control intestinal inflammation
88. Vaccines in historic evolution and perspective: A narrative of vaccine discoveries
89. Mucosal immunity, HIV transmission, and AIDS
90. The development of live attenuated cold-adapted influenza virus vaccine for humans
91. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen
92. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens
93. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant
94. Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induced Th2 cells in mucosa associated tissues
95. Optimizing oral vaccines: Induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant
96. The adjuvant effect of cholera toxin is associated with an increased intestinal permeability of luminal antigen
97. The adjuvant effect of Vibrio cholerae and Escherichia coli-heat labile enterotoxins is linked to their ADP-ribosyltransferase activity
98. Orally administered cholera toxin prevents murine intestinal T cells from staphylococcal enterotoxin B-induced anergy
99. A single amino acid substitution in the A subunit of Escherichia coli enterotoxin results in a loss of its toxic activity
100. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrhoeagenicity but retain adjuvanticity
101. Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women
102. Genital secretory immune response to chronic SIV infection: A comparison between intravenously and genitally inoculated rhesus macaques
103. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
104. Human neutralizing monoclonal antibodies to the IgG1 subtype protect against mucosal simian/human immunodeficiency virus infection
105. IgG surfaces as an important component in mucosal protection
106. gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues
107. gag and cholera toxin elicits both mucosal IgA and systemic IgG1 immune responses in non-human primates
108. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type response to an oral vaccine without altering mucosal IgA responses
109. IL-12 is an effective adjuvant for induction of mucosal immunity
110. Live oral avirulent Salmonella vaccines
111. Regulation of host immune responses by modification of Salmonella virulence genes
112. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex glycoprotein
113. Immunogenicity recombinant adenovirus-recombinant syncytial virus vaccines with adenovirus types 4, 5 and 7 vectors dogs and a chimpanzee
114. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene
115. A tissue-specific endothelial cell molecule involved in lymphocyte homing
116. Recent advances in chemokines and chemokine receptors
117. Chemokines and the arrest of lymphocytes rolling under flow conditions
118. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules
119. Regional specialization in the mucosal immune system: Primed cells do not always home along the same track
120. Laryngeal secretory IgA and bacterial adherence to nasal mucosal cells
121. Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens
122. A three-tiered view of the role of IgA in mucosal defense